Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
about
Cancer classification in the genomic era: five contemporary problemsGlioblastoma Circulating Cells: Reality, Trap or Illusion?Heterogeneity of epidermal growth factor receptor signalling networks in glioblastomaExpression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomasMacrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.A peptide derived from apoptin inhibits glioma growth.Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.Collateral Lethality: A new therapeutic strategy in oncologyChromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours.Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes.Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastomapH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in GlioblastomaIn vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastomaGenetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.Pediatric gliomas as neurodevelopmental disordersOlig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.ABCG1 maintains high-grade glioma survival in vitro and in vivo.Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion.Platelet-derived growth factor in glioblastoma-driver or biomarker?Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?Glycosylation alterations in lung and brain cancer.Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaGlioblastoma: pathology, molecular mechanisms and markers.Implications of mitogen-activated protein kinase signaling in glioma.Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
P2860
Q26781783-0099F1A6-A274-459F-A21C-AC8F86737A3BQ26823823-BB0C3502-D6BC-4014-A400-D66647589666Q27013006-A6EEAADA-E454-4DCE-A912-352A0E06354CQ30275293-864B601E-5E43-4F0E-B746-B453A35D8A3AQ30276928-F2B8E0FF-94C5-4E9D-8D76-7981F021D81BQ33646231-3BE03D2F-1B43-412C-959D-8AC2E8436818Q33744491-69A1A754-B3F9-4185-BA9B-04E41725ACD9Q33744534-6476D336-D446-4606-86AB-8B103B5B2D4CQ33761660-7E26E084-C3A1-4AE5-8829-D18AC68D73A8Q33777905-56E4FAF3-E5D3-4381-BCA1-0ADFF9346ACAQ33786677-DEF8072C-ADF8-49EC-8F51-381AD54DEF80Q34513800-134CA87D-5105-4D6B-8670-02D8F6191690Q35128022-CFA10F3A-6901-4DB0-8D1F-100F637F9167Q35306157-EFA18E9E-93CB-4506-8F91-2AB4C04D73BCQ35376154-0B0EE612-810D-4275-B6F1-CE9757D34614Q35573268-3C81226C-D364-4517-AC2C-49FEBCBD3900Q36200482-0E2CE29A-AA29-41CC-9D19-76E1D0760CB0Q36232178-A14E92CC-85C9-43FF-860C-1D6B92B0F3CDQ36250650-1B8B96B9-8B33-4821-9D18-79243EA949FAQ36299611-8C671C2D-BDAD-42E0-B7DF-DEAEF45898AEQ36328555-DC490E4C-0641-413E-8FDD-9A161F5F4950Q36379857-C8B293F8-5B4B-4F88-9957-63081C28C660Q36803476-21D0004E-98C6-4AD0-A131-9A1DB78EFB2CQ37097023-BDF10A5C-E7D4-44F6-A4FA-A184E833C1D3Q37217995-242E906C-EDEC-40CF-B2AE-ECDCEEC22947Q37240846-42E1AD77-1CDE-4D7D-806E-3C2BE6C744B0Q37269034-3322A8CF-28A3-4980-9410-53991EF4C98EQ37269061-BC814624-264A-4F34-B50A-D8BDD5F4B53FQ37301799-905A52B9-53CE-459C-9635-C23E359DED18Q37649442-0E9D7450-9930-4560-A19B-F31F4F10EC9AQ37702754-8C1E1F64-1800-4755-AAF3-D1A6A75AED2BQ38262433-9BBB7284-F304-40F4-8D1B-00283005999FQ38364234-35B35CBF-480D-47DA-9FC3-87D236100325Q38366332-47638F37-2A95-44B6-88FE-879340AADC66Q38453759-642A2208-185F-46C5-80C9-A54CEA039DBAQ38460865-96A810C6-FB1A-414A-BD99-47B8421D193CQ38618205-B79B63FC-0483-42BD-914C-97DE6D4798E2Q38677899-5BEA28E8-F422-4797-A717-144DBCC7861EQ38732473-479BFE5E-0897-4E79-818B-BC0D68788C1DQ38737715-CE30D20E-0E64-4A7B-9908-C3448C65B024
P2860
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@ast
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@en
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@nl
type
label
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@ast
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@en
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@nl
prefLabel
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@ast
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@en
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@nl
P2093
P2860
P1433
P1476
Most human non-GCIMP glioblast ...... roneural-like precursor glioma
@en
P2093
Eric C Holland
Franziska Michor
Jason T Huse
Karim Helmy
Nikki Charles
Tatsuya Ozawa
Yu-Kang Cheng
P2860
P304
P356
10.1016/J.CCR.2014.06.005
P577
2014-08-01T00:00:00Z